Skip navigation

Lilly, Medtronic team up on Parkinson's strategy

U.S. drugmaker Eli Lilly and Co and device maker Medtronic Inc on Tuesday said they will test a drug for Parkinson's disease that has intrigued researchers over the past decade but repeatedly failed in clinical trials. Full story

Pain Therapeutics reports Remoxy abuse study data

Pain Therapeutics Inc. on Monday reported clinical study results that may indicate its pain drug candidate Remoxy is more difficult to abuse than OxyContin. Full story

Indiana police officers recognize suspect in court

A 19-year-old Richmond man attending his mother's drug trial this week was arrested in an unrelated theft case after officers recognized him in the courtroom. Full story

Pfizer says patient died in oral RA drug study

Pfizer Inc. confirmed that one patient who was taking its drug candidate tofacitinib, a pill designed to treat rheumatoid arthritis, died during a recent clinical trial and said the death was connected to the drug. Full story

HeartWare tumbles on blood clot concerns

Shares of HeartWare International Inc. fell Monday on reports that the company's heart-assist device was associated with a high rate of blood clots in a clinical trial. Full story

HeartWare device had 9.2 percent thrombosis rate in trial

Patients implanted with a mechanical heart-assistance device made by HeartWare International Inc have an unexpectedly high 9.2 percent chance of developing a potentially life-threatening blood clot per year, newly-released data shows. Full story

Sponsored Links


FDA orders safety studies for some asthma drugs

UPDATE 1-FDA orders safety studies for some asthma drugs

Ever the boss, NY Giants owner heads jury at trial

Folic acid fails in another heart-health study

Army starts clinical trials on ricin vaccine

Government Shutdown Would Threaten Time-Sensitive Clinical Research

Ahead of the Bell: Inhibitex shares tumble

NY Giants owner fumbles in bid to escape jury duty

NY Giants owner can't escape jury duty

Neurocrine Tardive drug meets midstage study goals


  What mammogram advice really means

Nov. 19:  Health and Human Services Secretary Kathleen Sebelius is telling American women and insurance companies to keep doing what they’ve been doing about breast cancer screening. Dr. Nancy Snyderman talks with a panel of experts.

  When medical tests fail

Nov. 2: Patients who participate in clinical trials aren’t always notified if the medical device or drug being tested fails. How can participants in trials protect themselves? Dr. Nancy Snyderman talks with a panel of experts.

  Doctor shares insider’s tips

Nov. 2: From prescriptions to clinical trials and insurance, Dr. Billy Goldberg, author of “Why Do Men Have Nipples,” fills you in on the things your doctor isn’t telling you.

  Official: H1N1 vaccine 'going to be effective'

Oct. 25: NBC’s Lester Holt speaks with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease.

  Being tall at any risk

Oct. 19:  More parents of children who are short but otherwise healthy are turning to human growth hormone to give their children a leg up, literally. Dr. Nancy Snyderman talks with a panel of experts about where to draw the line on medical solutions for being short.

advertisement | ad info

Related Photos


Registered Nurse Ruthann Schrock administers a standard flu vaccine to Will Ross, 16, of Iowa City, Iowa during the start of a clinical trial on when the H1N1 flu shot should be given with the seasonal shot to make it most effective Monday, Aug. 31, 2009 at the University of Iowa Children's Hospital


Geoffrey von Maltzahn has figured out ways to use tiny particles of gold to seek out and destroy cancer cells without side effects such as hair loss and nausea associated with chemotherapies. Gold nanorods rods are injected into the bloodstream and infiltrate pores in rapidly growing tumor blood ves

H1N1 flu vaccine
H1N1 flu vaccine

FILE - This Aug. 10, 2009 file photo shows research nurse Wendy Nesheim drawing H1N1 flu vaccine into a syringe to administer to volunteer participants during first of several clinical trials conducted by Emory University in Atlanta. A White House report from an expert panel suggests that from 30 pe

Dr. Lisa Jackson
Dr. Lisa Jackson

Dr. Lisa Jackson, a researcher with Group Health Center for Health Studies, who is a chief investigator for the H1N1 clinical trials, participates in a Swine Flu conference call at her Seattle office on July 27.